An Open-Label Exploratory Study With Memantine: Assessment of Selected Measures of Volumetric MRI [magnetic resonance imaging] and Cognition in Patients With Moderate Dementia of the Alzheimer's Type
Phase of Trial: Phase IV
Latest Information Update: 18 Jan 2010
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 04 Jan 2008 Status changed from in progress to completed.
- 21 Oct 2006 New trial record.